| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-catenin and TCF-4) in -catenin-dependent nuclear signaling and cadherin functions
1 Department of Cell Biology, University of Virginia School of Medicine, Charlottesville, VA, USA
* To whom correspondence should be addressed. E-mail: gottardc{at}mskcc.org.
ICAT is 9kDal polypeptide that inhibits 
-catenin nuclear signaling by binding -catenin and competing its interaction with the transcription factor, TCF, but basic characterization of the endogenous protein and degree to which it alters other -catenin functions is less well understood. At the subcellular level, we show that ICAT localizes to both cytoplasmic and nuclear compartments. In intestinal tissue, ICAT is up-regulated in the mature, non-dividing enterocyte population lining intestinal villi and is absent in the -catenin/TCF signaling-active crypt region, suggesting that its protein levels may be inversely related with -catenin signaling activity. However, ICAT protein levels are not altered by activation or inhibition of Wnt signaling in cultured cells, suggesting that ICAT expression is not a direct target of the Wnt/-catenin pathway. In cells where -catenin levels are elevated by Wnt, a fraction of this -catenin pool is associated with ICAT, suggesting that ICAT may buffer the cell from increased levels of -catenin. Distinct from TCF and cadherin, ICAT does not protect the soluble pool of -catenin from degradation by the APC-containing "destruction complex". While ICAT inhibits -catenin binding to the cadherin as well as TCF in vitro, stable overexpression of ICAT in MDCK epithelial cells shows no obvious alterations in the cadherin complex, suggesting that ICAT's ability to inhibit -catenin binding to the cadherin may be restricted in vivo. MDCK cells overexpressing ICAT do, however, exhibit enhanced cell scattering upon Hepatocyte Growth Factor (HGF)-treatment, suggesting a possible role in the regulation of dynamic, rather than steady state cell-cell adhesions. These findings confirm ICAT's primary role in -catenin signaling inhibition, and further suggest that ICAT may have consequences for cadherin-based adhesive function in certain circumstances, implying a broader role than previously described.
This article has been cited by other articles:
|
|
 |
|
  R. Mo, T.-L. Chew, M. T. Maher, G. Bellipanni, E. S. Weinberg, and C. J. Gottardi The Terminal Region of {beta}-Catenin Promotes Stability by Shielding the Armadillo Repeats from the Axin-scaffold Destruction Complex J. Biol. Chem., October 9, 2009; 284(41): 28222 - 28231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Maher, A. S. Flozak, A. M. Stocker, A. Chenn, and C. J. Gottardi Activity of the {beta}-catenin phosphodestruction complex at cell-cell contacts is enhanced by cadherin-based adhesion J. Cell Biol., July 27, 2009; 186(2): 219 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Arikkath, I. Israely, Y. Tao, L. Mei, X. Liu, and L. F. Reichardt Erbin Controls Dendritic Morphogenesis by Regulating Localization of {delta}-Catenin J. Neurosci., July 9, 2008; 28(28): 7047 - 7056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Z. Hossain, Q. Yu, M. Xu, and J. M. Sen ICAT expression disrupts {beta}-catenin-TCF interactions and impairs survival of thymocytes and activated mature T cells Int. Immunol., July 1, 2008; 20(7): 925 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Guo, J. W. Breslin, M. H. Wu, C. J. Gottardi, and S. Y. Yuan VE-cadherin and {beta}-catenin binding dynamics during histamine-induced endothelial hyperpermeability Am J Physiol Cell Physiol, April 1, 2008; 294(4): C977 - C984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Herington, J. Bi, J. D. Martin, and B. M. Bany {beta}-Catenin (CTNNB1) in the Mouse Uterus During Decidualization and the Potential Role of Two Pathways in Regulating Its Degradation J. Histochem. Cytochem., September 1, 2007; 55(9): 963 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Strom, C. Bonal, R. Ashery-Padan, N. Hashimoto, M. L. Campos, A. Trumpp, T. Noda, Y. Kido, F. X. Real, F. Thorel, et al. Unique mechanisms of growth regulation and tumor suppression upon Apc inactivation in the pancreas Development, August 1, 2007; 134(15): 2719 - 2725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.-S. Chou, P.-S. Wang, S. Kulp, and J. J. Pinzone Effects of Thiazolidinediones on Differentiation, Proliferation, and Apoptosis Mol. Cancer Res., June 1, 2007; 5(6): 523 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Gottardi and B. M. Gumbiner Distinct molecular forms of {beta}-catenin are targeted to adhesive or transcriptional complexes J. Cell Biol., October 25, 2004; 167(2): 339 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Stow ICAT is a multipotent inhibitor of {beta}-catenin. Focus on "Role for ICAT in {beta}-catenin-dependent nuclear signaling and cadherin functions" Am J Physiol Cell Physiol, April 1, 2004; 286(4): C745 - C746. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
